MSB 2.17% $1.13 mesoblast limited

Upcoming Newsflow & Re-rate Estimations, page-36

  1. 226 Posts.
    lightbulb Created with Sketch. 18
    Well im certainly no expert but the current GLOBAL market forcast for cell and gene therapy by 2032 is expected to be $44B.......ur talking msb alone to be a $50B company...so unless ur talking the next 10-15 (minimum)? Years then i personally think its unrealistic.....look,like i said iv got alot invested here and have been in and havent sold a share in 4+years and i hope im completely wrong on this but i just cant see $50aud per share at least in the next 10-15 years
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.